Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Pharmanet Names Dr. George Scott Vice President of Bioanalytical Services

Published: Friday, July 22, 2011
Last Updated: Friday, July 22, 2011
Bookmark and Share
Dr. Scott will provide leadership for PharmaNet's GLP-compliant bioanalytical laboratories in the United States and Canada.

PharmaNet Development Group, Inc., has announced that it has appointed George Scott, PhD, as Vice President, Bioanalytical Services.

In this role, Dr. Scott will provide leadership for PharmaNet's GLP-compliant bioanalytical laboratories in the United States and Canada.

In addition, he will build upon PharmaNet's bioanalytical method development, validation and sample analysis services across the continuum of drug development and lead PharmaNet's geographical and service expansion strategies in bioanalysis.

"Dr. Scott has a very impressive scientific and operational experience base in bioanalysis," commented Riaz Bandali, President, Early Stage Development. "He has extensive knowledge of our clients' needs and is highly regarded in the industry for his scientific expertise and his business acumen."

Prior to joining PharmaNet, Dr. Scott served as Director of Pharmacokinetics and Drug Metabolism at Amgen, a world leader in biotechnology. He was responsible for overseeing the immunochemistry and small molecule bioanalytical capabilities.

He was also integrally involved in the Amgen Leadership Committee that managed strategic outsourcing decisions for small molecule and large molecule programs to global bioanalytical service providers.

Prior to Amgen, Dr. Scott was responsible for establishing and growing the global ligand binding services at another CRO.

Dr. Scott holds a Bachelors of Science in Neuroscience from Edinburgh University and was awarded a PhD from the University of Nottingham for studies in neuropharmacology.

After four years in post-doctoral positions at Dalhousie University and the University of Montreal, he served for two years as an Assistant Professor in the faculty of Dentistry at McGill University.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PharmaNet’s Bioanalytical Laboratory Recognized by the Standards Council of Canada for Good Laboratory Practice Compliance
OECD GLP recognition consolidates Company’s position as the partner of choice for companies seeking assured international registration of their products.
Wednesday, June 29, 2011
Valerie Palumbo Joins Pharmanet as Senior Vice President, Corporate Quality Assurance
Ms. Palumbo has more than twenty years of experience in the development and implementation of quality assurance programs in the FDA-regulated drug and medical device industries.
Tuesday, May 03, 2011
Pharmanet Appoint New Chief Medical Officer
PharmaNet Development Group, Inc. announces that Jeffrey Freitag, M.D., Senior Vice President, PharmaNet Consulting, will expand his role to become Chief Medical Officer of PharmaNet.
Monday, February 21, 2011
PharmaNet Launches New Brand Identity
PharmaNet Development Group, Inc. announced that it is launching a new brand identity and tagline, “PharmaNet Works For You”. The new brand and tagline reflect the Company’s promise to its clients to provide intelligent solutions to accelerate drug development programs consistent with the highest standards of regulatory compliance, quality and reliability.
Thursday, November 25, 2010
PharmaNet Development Group Collaborates with Abacus International
Collaboration is aimed to support patient registries and health economic programs in Europe.
Monday, July 26, 2010
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Analysis Technique for Chiral Activity in Molecules
Professor Hyunwoo Kim of the Chemistry Department and his research team have developed a technique that can easily analyze the optical activity of charged compounds by using nuclear magnetic resonance (NMR) spectroscopy.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Antibiotics on Our Plates 'Could Lead to Health Catastrophe'
Two medical experts from The University of Queensland are urging China to curb its use of antibiotics in animals to avoid what could be a ‘major health catastrophe’ for humans.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos